Daiichi-Sankyo (South Korea)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi-Sankyo (South Korea), South Korea, covering academic research published from 2002 to 2025. Read More.
Open Access Percentage
69%
Total
Publications
268
Total Open
Publications
185
Total
Citations
6.6K
Open Access
Percentage
69%
Total
Publications
268
Total Open
Publications
185
Total
Citations
6.6K
Breakdown
Publisher Open
24%
Both
29%
Other Platform Open
16%
Closed
31%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 25%
35
Hybrid 29%
40
No Guarantees 46%
64
Other Platform Open
Domain 63%
75
Institution 33%
39
Other Internet 16%
19
Preprint 12%
14
Public 1%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 79 |
doaj.org OAI-PMH Repository | Institution | 14 |
Research Square | Preprint | 11 |
Unknown Repository | Other Internet | 10 |
DOI | Other Internet | 10 |
Royal Netherlands Academy of Arts and Sciences | Institution | 5 |
National Institute of Informatics | Institution | 3 |
kuleuven.be OAI-PMH Repository | Institution | 3 |
Erasmus University Rotterdam | Institution | 3 |
Yonsei University | Institution | 2 |